Abstract. The incidence of hepatocellular carcinoma (HCC) in Japan is still increasing. The aim of the present study was to analyze the epidemiological trend of HCC in the Western area of Japan, Nagasaki. A total of 1,807 patients with HCC diagnosed at our two hospitals between 1981 and 2005 were consecutively recruited for this study. Cohorts of patients with HCC were categorized into five-year intervals.
Introduction
Primary liver cancer is the most common primary cancer of the liver accounting for ~6% of all human cancers. It is estimated that half a million cases occur worldwide annually, making primary liver cancer the fifth most common malignancy in men and the ninth in women (1) (2) (3) (4) (5) (6) . Hepatocellular carcinoma (HCC) accounts for 85 to 90% of primary liver cancers (7) and the age-adjusted HCC mortality rate has increased in recent decades in Japan (8) . Similarly, a trend of increasing rates of HCC has been reported from several developed countries in North America, Europe and Asia (9, 10) . HCC often develops in patients with liver cirrhosis caused by hepatitis B virus (HBV), hepatitis C virus (HCV), excessive alcohol consumption, or nonalcoholic fatty liver disease. Of the hepatitis viruses which cause HCC, HCV is predominant in Japan (11) (12) (13) (14) .
Although the age-adjusted incidence of HCC has increased in Japan, sequential changes in background features of HCC patients are not fully understood (15) . Yoshizawa reports that deaths due to HCC in Japan have continued to increase in males, particularly in those older than 60 years of age in the past 3 decades, although the reasons for this are unclear (16) . To clarify factors affecting epidemiological changes in Japanese HCC patients, especially the change in age distribution and gender, we analyzed the underlying features of HCC patients in a two major liver center-based study.
Patients and methods

Patients.
A total of 1,807 patients with HCC diagnosed between January 1981 and December 2005 in the Liver Disease Center, National Nagasaki Medical Center and in the outpatient clinic of The First Department of Internal Medicine, Nagasaki University Hospital, were consecutively recruited for this study. The diagnosis of HCC was based on AFP levels and imaging techniques including ultrasonography (USG), computerized tomography (CT), magnetic resonance imaging (MRI), hepatic angiography (HAG) and/or tumor biopsy. The diagnostic criteria for HCC were either a confirmative tumor biopsy or elevated AFP (≥20 ng/ml) and neovascularization in HAG and/or CT. Cohorts of patients with HCC were categorized into five-year intervals (1981-1985, 1986-1990, 1991-1995, 1996-2000 and 2001-2005 
Results
Clinical features of the studied patients.
A total of 1,807 patients with HCC were diagnosed at our hospital from 1981 to 2005. There were 1,347 male (75%) and 460 female (25%) patients, with a median age of 64 years. The proportion of patients diagnosed as HCC-B (HBV-associated: HBsAg positive, HCVAb negative) was 23% (412 of 1,807), whereas 63% (1,134 of 1,807) had HCC-C (HCV-associated: HCVAb positive, HBsAg negative) and an additional 3% (46 of 1,807) had HCC associated with both viruses. The remaining 215 patients (12%) showed both of the virus markers negative.
As shown in Table I and Fig. 1 , the number and proportion of HCC-B cases decreased from 1986 to 1990 and thereafter stabilized, whereas those of HCC-C reached the peak in the period 1996-2000 and thereafter decreased. The number and proportion of the HCC-nonBC (HBsAg and HCVAb negative) cases continued to increase in the whole period.
Background features for patients with HCC. Fig. 2 shows the median age at diagnosis of HCC-B, HCC-C and HCC-nonBC in five-year intervals (1981-1985, 1986-1990, 1991-1995, 1996-2000 and 2001-2005) . The median age of patients at diagnosis of HCC-C showed a steadily significant increase from 58 to 69 years of age during the period. The median age of patients with HCC-B and HCC-nonBC did not significantly change during the period. Fig. 3 shows the age distribution of patients with HCC-B and HCC-C with the five 5-year intervals. There was no difference in the age distribution of patients with HCC-B during these periods. In contrast, HCC-C obviously had a trend to increase in the number of patients aged >65 years. Table I shows that the male/female ratio of HCC patients decreased from 4.2 in the period 1981-1985 to 2.1 in 2001-2005, indicating clearly the increase of female patients. In analysis of patients in HCC-C, the male/female ratio in the periods 1981-1985, 1986-1990, 1991-1995, 1996- Table II) . The ratio became clearly smaller, indicates an increase in female patients with HCC-C. On the other hand, the male/female ratio of other types of HCC patients did not significantly change during the period.
Discussion
This was a two major liver center-based study designed to examine the sequential change in the background of HCC patients during the past 25 years, 1981-2005. More than 80% of our patients had chronic HBV or HCV infections. During the observation period, the number and proportion of HCC-B cases decreased in the period 1986-1990 and thereafter reached a plateau, whereas HCC-C reached a peak in the period 1995-2000 and thereafter slightly decreased. On the other hand, the number and the proportion of HCC-nonBC gradually increased in the periods of 1981-1985, 1986-1990, 1991-1995, 1996- Period  1981-1985  1986-1990  1991-1995  1996-2000  2001-2005  Total  - 
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period of 1981-2001 (8,15,17-19) . However, in our study, the number and proportion of HCC-C cases decreased in the period [2001] [2002] [2003] [2004] [2005] . This may be due to interferon therapy associated with a decreased incidence of HCC (20) (21) (22) (23) (24) . Iron depletion for chronic hepatitis C patients is a promising modality for lowering the risk of progression to HCC (25, 26) . Oral supplementation with oral branched-chain amino acids has been useful in the prevention HCC (27) . Finally, the chronically HCV-infected population is aging in Japan. Yoshizawa reported that age-specific prevalence for the presence of HCVAb among ~300,000 voluntary blood donors from Hiroshima in 1999 clearly increased with the 1996-2000 vs. 1986-1990 p=0.0084; 1991-1995 vs. 1981-1985 p=0.0024 and 1991-1995 vs. 1986-1990 p=0.0058.
age, reaching the highest proportion of 7% in individuals who were >70 years old (15, 16) . In this study, the median age of patients with HCC-C steadily increased from 58 to 69 years of age during the studied period. i.e. HCV infected people become older and they were regarded as a high risk for HCC.
In almost all populations, males have higher liver cancer proportions than females, with the male/female ratios usually averaging between 2:1 and 4:1 (7). However, the male/female ratio of HCC in Japan was 4.5 in the period 1983-1985 and 2.57 in 2000-2001 (17) . In analysis of background features among HCC patients, HCC-B and HCC-nonBC cases revealed no significant change, whereas the male/female ratio of patients with HCC-C steadily decreased from 6.4 to 1.9 during the period. We suggest that the increase of female patient with HCC-C was caused by the aging of HCV infected people. The increase of females among HCC patients was considered to increase because of HCC-C.
It is known that 2 to 4 decades of chronic HCV infection are required to develop cirrhosis and subsequent HCC (28) (29) (30) (31) . The number of HCC cases has increased in Japan, because individuals infected with HCV in the past have grown old and have reached the cancer-bearing age. The prevalence of HCV infection in young Japanese individuals is low and the incidence of HCVAb is very low because of preventative actions against HCV infection such as the screening of blood products for HCV and the use of sterile medical equipment (32) . Additionally, we showed that the number and proportion of patients with HCC-C cases decreased together with an increase in the median age, whereas the number and ratio of HCC-nonBC steadily increased during the studied period. Based on these findings it may be expected that the incidence of HCC-nonBC in Japan may continue to increase even after the consequence of the HCV epidemic level off in the near future, although Japan is far advanced with regard to HCC-C.
In summary, HCC patients rapidly increased from 1981 to 2000 and this increase originated from HCC-C and the increase of the median age and the number of female patients with HCC-C. Increase in the number and proportion of the HCC-nonBC patients are also significant.
